Compliant Analysis of Patient Samples and Data

Enrolling by invitation

Conditions studied: Pregnancy Related, Cancer, Infectious Disease

In brief

Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.

Key facts

Study ID: NCT04364503
Run by: Sequenom, Inc.
People needed: 2000
Starts: 2018-03-17
Expected to finish: 2030-08-15
Last updated by the study team: 2026-07-21

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Arm 1
All samples and data are de-identified and HIPAA compliant
Arm 2
Subject is of scientific interest to the Sponsor or treating physician
Subject provides written informed consent and has a clinical sample and/or supporting clinical data collected.

You may not qualify if…

Arm 1
Subject is from a US state or a country where local law restricts the use of de-identified data and/or remnants of specimens for research and/or development
Arm 2
Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent

Where it is running

Labcorp — Los Angeles, California, United States
Sequenom, Inc — San Diego, California, United States
Labcorp - Monogram Biosciences — South San Francisco, California, United States
Labcorp - Esoterix — Englewood, Colorado, United States
Labcorp - Litholink — Itasca, Illinois, United States
Labcorp - Omniseq — Buffalo, New York, United States
Labcorp — Burlington, North Carolina, United States
Labcorp - Cytogenetics — Research Triangle Park, North Carolina, United States
Labcorp — Research Triangle Park, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.